Skip to main content
IlluminaPatent grant

Illumina was granted a patent for haplotype-aware genome analysis.

Source: Autobound Signal API · 103 signals tracked for Illumina · updated

Get Illumina's live signals in Claude or ChatGPT, or by API

AskWhat changed at Illumina this week? Use Autobound signals for illumina.com.

What happened

In October 2026 Illumina patented a genome-analysis approach for improving variant detection in sequencing workflows and genomic research.

Source

patents.google.comOct 27, 2026

US patent US12776389

Graph reference genome and base-calling approach using imputed haplotypes

Abstract

The present disclosure relates to systems, non-transitory computer-readable media, and methods for generating a graph reference genome customized for a particular sample genome and utilizing the customized graph reference genome to determine final nucleotide-base calls for the sample genome. To illustrate, the disclosed systems can generate a customized graph reference genome including various paths representing imputed haplotypes corresponding to a particular genomic region. Additionally, or alternatively, the disclosed system can determine and compare direct and imputed nucleotide-base calls for a sample genome as a basis for generating final nucleotide-base calls. In some such cases, the disclosed system weights (and selects between) direct nucleotide-base calls and imputed nucleotide-base calls for genomic coordinates based on sequencing metrics corresponding to the direct nucleotide-base calls or based on the variability of the genomic regions comprising the genomic coordinates.

patents.google.com/patent/US12776389Read the full source

Extracted by Autobound

From the Signal API record
Signal
Patent grant

What this signalsA new patent often shows where a company is putting its R&D budget.

Grant date
Oct 27, 2026
Inventors
Michael A Eberle
Patent number
US12776389
Assignee
Illumina, Inc.

The full record

From the Signal API record

People

  • Michael A EberleInventor

Details

Primary CPC class
G16B 20/20
USPTO assignee
Illumina, Inc.
What the invention does
A method that builds a sample-specific map of possible DNA sequences, then uses it to make more accurate base calls from sequencing data.

Topics and mentions

Tags

  • Intellectual Property
  • Research & Development
  • Medical Research
  • Healthcare Technology

Technologies named

  • genome sequencing
  • variant calling
  • haplotype analysis
  • bioinformatics

Extraction

Detected
Oct 30, 2026
signal_type
patents-company
signal_subtype
patentGrant

Use this data

Get every patent signal for Illumina and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Illumina this week?”

  2. Send it to your own tools

    The Signal API returns patent signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full patents-company record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/1ea0fbb7-4ead-592f-b7c4-5a3a39ce79f5 returns this record as JSON. POST /v1/companies/enrich returns every signal for illumina.com.

{
  "signal_id": "1ea0fbb7-4ead-592f-b7c4-5a3a39ce79f5",
  "signal_type": "patents-company",
  "signal_subtype": "patentGrant",
  "detected_at": "2026-10-30T00:44:52+00:00",
  "company": {
    "name": "Illumina",
    "domain": "illumina.com"
  },
  "data": {
    "cpc": [
      {
        "code": "G16B 20/20"
      },
      {
        "code": "G16B 45/00"
      }
    ],
    "tags": [
      "Intellectual Property",
      "Research & Development",
      "Medical Research",
      "Healthcare Technology"
    ],
    "detail": "In October 2026 Illumina patented a genome-analysis approach for improving variant detection in sequencing workflows and genomic research.",
    "summary": "Illumina was granted a patent for haplotype-aware genome analysis.",
    "event_at": "2026-10-27",
    "inventors": [
      {
        "name": "Michael A Eberle",
        "status": "resolved",
        "is_primary": true,
        "linkedin_url": "https://www.linkedin.com/in/michael-eberle-aa724344"
      }
    ],
    "event_kind": "grant_date",
    "grant_date": "2026-10-27",
    "source_url": "https://patents.google.com/patent/US12776389",
    "cpc_primary": {
      "code": "G16B 20/20"
    },
    "patent_title": "Graph reference genome and base-calling approach using imputed haplotypes",
    "patent_number": "US12776389",
    "uspto_assignee": "Illumina, Inc.",
    "patent_abstract": "The present disclosure relates to systems, non-transitory computer-readable media, and methods for generating a graph reference genome customized for a particular sample genome and utilizing the customized graph reference genome to determine final nucleotide-base calls for the sample genome. To illustrate, the disclosed systems can generate a customized graph reference genome including various paths representing imputed haplotypes corresponding to a particular genomic region. Additionally, or alternatively, the disclosed system can determine and compare direct and imputed nucleotide-base calls for a sample genome as a basis for generating final nucleotide-base calls. In some such cases, the disclosed system weights (and selects between) direct nucleotide-base calls and imputed nucleotide-base calls for genomic coordinates based on sequencing metrics corresponding to the direct nucleotide-base calls or based on the variability of the genomic regions comprising the genomic coordinates.",
    "precision_class": "structural",
    "invention_explanation": "A method that builds a sample-specific map of possible DNA sequences, then uses it to make more accurate base calls from sequencing data.",
    "technologies_mentioned": [
      "genome sequencing",
      "variant calling",
      "haplotype analysis",
      "bioinformatics"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.